In addition to its previously mentioned effect on PD-1L, there is also evidence indicating that combined treatment with immunomodulatory doses of EGCG can boost the immune response of specific CD8 + T lymphocytes and CD4 + Th1 lymphocytes induced by DNA vaccine, thereby offering long-term protection against cancer [165]. Here, CD8A is linked to cancer.